Yuki Kamimoto

600 total citations
27 papers, 432 citations indexed

About

Yuki Kamimoto is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Yuki Kamimoto has authored 27 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Obstetrics and Gynecology, 11 papers in Pediatrics, Perinatology and Child Health and 7 papers in Hematology. Recurrent topics in Yuki Kamimoto's work include Pregnancy and preeclampsia studies (11 papers), Birth, Development, and Health (5 papers) and Maternal and fetal healthcare (4 papers). Yuki Kamimoto is often cited by papers focused on Pregnancy and preeclampsia studies (11 papers), Birth, Development, and Health (5 papers) and Maternal and fetal healthcare (4 papers). Yuki Kamimoto collaborates with scholars based in Japan, Sweden and United States. Yuki Kamimoto's co-authors include Takashi Umekawa, Nao Murabayashi, Takashi Sugiyama, Norimasa Sagawa, Ning Ma, Tomoaki Ikeda, Hiroaki Tanaka, Masafumi Nii, Kazuhiro Osato and Michiko Kubo and has published in prestigious journals such as PLoS ONE, Endocrinology and Diabetologia.

In The Last Decade

Yuki Kamimoto

27 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuki Kamimoto Japan	12	233	195	73	65	58	27	432
Nao Murabayashi Japan	12	247 1.1×	160 0.8×	69 0.9×	60 0.9×	36 0.6×	24	428
Tsutomu Ishizuka Japan	9	86 0.4×	145 0.7×	68 0.9×	81 1.2×	48 0.8×	15	496
Yu‐Wen Hsu Taiwan	9	108 0.5×	67 0.3×	70 1.0×	77 1.2×	32 0.6×	14	377
Elżbieta Poniedziałek‐Czajkowska Poland	11	169 0.7×	195 1.0×	22 0.3×	37 0.6×	33 0.6×	34	377
Hidetaka Nanno Japan	11	134 0.6×	204 1.0×	108 1.5×	56 0.9×	57 1.0×	15	437
Åse Vårtun Norway	12	333 1.4×	441 2.3×	24 0.3×	83 1.3×	118 2.0×	23	658
Thalita Frutuoso Lobo Brazil	8	339 1.5×	375 1.9×	22 0.3×	59 0.9×	91 1.6×	11	562
Balázs Stenczer Hungary	15	135 0.6×	292 1.5×	39 0.5×	44 0.7×	292 5.0×	30	544
A. Garofano France	7	482 2.1×	247 1.3×	138 1.9×	60 0.9×	35 0.6×	9	732
Grażyna Kurzawińska Poland	10	95 0.4×	116 0.6×	12 0.2×	37 0.6×	57 1.0×	55	344

Countries citing papers authored by Yuki Kamimoto

Since Specialization

Citations

This map shows the geographic impact of Yuki Kamimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Kamimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Kamimoto more than expected).

Fields of papers citing papers by Yuki Kamimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Kamimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Kamimoto. The network helps show where Yuki Kamimoto may publish in the future.

Co-authorship network of co-authors of Yuki Kamimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Kamimoto. A scholar is included among the top collaborators of Yuki Kamimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Kamimoto. Yuki Kamimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanaka, Hiroaki, Yuki Kamimoto, Takashi Sugiyama, et al.. (2020). Relationship between a high Edinburgh Postnatal Depression Scale score and premenstrual syndrome: A prospective, observational study. Taiwanese Journal of Obstetrics and Gynecology. 59(3). 356–360. 5 indexed citations

Sugimoto, Masahiko, Mineo Kondo, Yuki Kamimoto, et al.. (2019). Changes in VEGF-related factors are associated with presence of inflammatory factors in carbohydrate metabolism disorders during pregnancy. PLoS ONE. 14(8). e0220650–e0220650. 5 indexed citations

Sugimoto, Masahiko, Ryohei Miyata, Hisashi Matsubara, et al.. (2019). Relationship between Size of the Foveal Avascular Zone and Carbohydrate Metabolic Disorders during Pregnancy. BioMed Research International. 2019. 1–7. 4 indexed citations

Tanaka, Hiroaki, et al.. (2018). In utero spontaneous bladder rupture in a fetus with posterior urethral valve: A case report of prenatal diagnosis and management. Journal of obstetrics and gynaecology research. 44(7). 1318–1321. 5 indexed citations

Umekawa, Takashi, Shintaro Maki, Michiko Kubo, et al.. (2018). TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial. BMJ Open. 8(10). e020948–e020948. 8 indexed citations

Tanaka, Kayo, Hiroaki Tanaka, Shintaro Maki, et al.. (2018). Cardiac function and tadalafil used for treating fetal growth restriction in pregnant women without cardiovascular disease. The Journal of Maternal-Fetal & Neonatal Medicine. 32(15). 2460–2462. 5 indexed citations

Habe, Koji, Hideo Wada, Takeshi Matsumoto, et al.. (2016). Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura. Internal Medicine. 55(6). 589–595. 15 indexed citations

Osato, Kazuhiro, Michiko Kubo, Masafumi Nii, et al.. (2016). Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report. Journal of Medical Case Reports. 10(1). 317–317. 12 indexed citations

Ikejiri, Makoto, Hideo Wada, Norikazu Yamada, et al.. (2016). High prevalence of congenital thrombophilia in patients with pregnancy-related or idiopathic venous thromboembolism/pulmonary embolism. International Journal of Hematology. 105(3). 272–279. 6 indexed citations

10.

Habe, Koji, Hideo Wada, Takeshi Matsumoto, et al.. (2016). Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome. Clinical and Applied Thrombosis/Hemostasis. 23(6). 622–630. 12 indexed citations

11.

Kamimoto, Yuki & Hideo Wada. (2015). [Pregnancy-Related Venous Thromboembolism].. PubMed. 63(12). 1419–26. 2 indexed citations

12.

Kamimoto, Yuki, Hideo Wada, Makoto Ikejiri, et al.. (2015). High frequency of decreased antithrombin level in pregnant women with thrombosis. International Journal of Hematology. 102(3). 253–258. 6 indexed citations

13.

Kamimoto, Yuki, Hideo Wada, Makoto Ikejiri, et al.. (2015). Hypofibrinogenemia and the α-Fibrinogen Thr312Ala Polymorphism may be Risk Factors for Early Pregnancy Loss. Clinical and Applied Thrombosis/Hemostasis. 23(1). 52–57. 9 indexed citations

14.

Umekawa, Takashi, Takashi Sugiyama, Nao Murabayashi, et al.. (2014). A maternal mouse diet with moderately high-fat levels does not lead to maternal obesity but causes mesenteric adipose tissue dysfunction in male offspring. The Journal of Nutritional Biochemistry. 26(3). 259–266. 21 indexed citations

15.

Habe, Koji, Hideo Wada, Takeshi Matsumoto, et al.. (2013). Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases. International Journal of Hematology. 97(3). 345–350. 8 indexed citations

16.

Murabayashi, Nao, Takashi Sugiyama, Yuki Kamimoto, et al.. (2013). Maternal high-fat diets cause insulin resistance through inflammatory changes in fetal adipose tissue. European Journal of Obstetrics & Gynecology and Reproductive Biology. 169(1). 39–44. 99 indexed citations

17.

Zhang, Lingyun, Takashi Sugiyama, Nao Murabayashi, et al.. (2011). The inflammatory changes of adipose tissue in late pregnant mice. Journal of Molecular Endocrinology. 47(2). 157–165. 44 indexed citations

18.

Kamimoto, Yuki, Takashi Sugiyama, Nao Murabayashi, et al.. (2010). Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy. Diabetologia. 53(9). 2046–2055. 28 indexed citations

19.

Umekawa, Takashi, Takashi Sugiyama, Nao Murabayashi, et al.. (2008). Overexpression of Thioredoxin-1 Reduces Oxidative Stress in the Placenta of Transgenic Mice and Promotes Fetal Growth via Glucose Metabolism. Endocrinology. 149(8). 3980–3988. 27 indexed citations

20.

Sugiyama, Takashi, Nao Murabayashi, Takashi Umekawa, et al.. (2008). Rapid overgrowth of a fetus after interruption of insulin therapy in a diabetic woman. Diabetes Research and Clinical Practice. 80(2). e9–e11. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact